VNS Therapy for Treatment-Resistant Depression
Objetivo
The purpose of this study is to track active VNS Therapy treatment in subjects with Treatment-Resistant Depression (TRD) and to better understand the reduction in the severity of baseline TRD symptoms. Data will be collected on your responses to study treatments, quality of life, productivity, and your use of healthcare services. Your participation in this study will consist of evaluations by the study doctor (or his/her designee), who will review your past and current medical and psychiatric history, and several questionnaires which you will complete during several follow-up visits over time.
Palabras clave: treatment resistant depression, VNS implant, medicare, surgery, depression, bipolar depression
Sitios de estudio
Keck Hospital of USC, 1500 San Pablo St, Los Angeles, CA 90033
- Men & Women
If several types of treatment for depression have not worked for you, or have not worked well enough, joining the RECOVER Study could give you a new opportunity to improve your quality of life.
To see if you are eligible contact Zoe Durkin at Zoe.Durkin@med.usc.edu.
Elegibilidad
Criterios de inclusión
- -18 years old or older
- -Current Depressed
- -Have depression, or bipolar depression, that has last at least two years or has recurred several times.
- -Have tried at least 4 antidepressant treatments and have not found them helpful.
Things to Consider
Benefits:
- By joining the RECOVER study, you have a chance of benefiting from an FDA-approved treatment for your depression that is not generally available unless you pay for it yourself.
- By joining, there is a possibility that your symptoms of depression will improve, or even resolve. You may experience an improved quality of life.
- Once activated, you will receive a continuous antidepressant therapy that's always with you.
- By taking part in the study, you might also be helping other people like you to access this treatment in the future.
- Whichever group you are in, you can continue to use your usual medications or therapies.
Risks / Drawbacks:
- Whichever group you are in, you'll need a short outpatient surgical procedure to implant the device.
- There is a 50/50 chance you will be in Group B. This means that, although you will receive a VNS device, active treatment will be delayed for the first 12 months of the study.
- The surgical procedure and stimulation from the device may sometimes cause side effects (unwanted changes in your health). Side effects are a risk with all medical procedures.
Compensation/Study Coverage
Study coverage will vary depending on your medicare insurance coverage. Please inquire with the study team. Compensation will be provided for each study visit to help pay for travel and for finishing the questionnaires.
Equipo del Programa
For questions about this study, contact:
- Research Coordinator Zoe Durkin
- 1333 San Pablo St, MCH B51A, Los Angeles, CA, 90033
- 323-422-6625
- zoe.durkin@med.usc.edu
Research study materials
We respect your privacy!
Toda la información que usted nos dé será guardada en una base de datos segura y protegida. Toda la información que usted decida compartir se mantendrá de manera confidencial y privada. Lea la Política de Privacidad de la universidad University of Southern California aquí.